Nishanta Singh
Overview
Explore the profile of Nishanta Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shinde V, Bhikha S, Hoosain Z, Archary M, Bhorat Q, Fairlie L, et al.
N Engl J Med
. 2021 May;
384(20):1899-1909.
PMID: 33951374
Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) pandemic. In a phase 1-2 trial involving healthy...
12.
Gray G, Bekker L, Laher F, Malahleha M, Allen M, Moodie Z, et al.
N Engl J Med
. 2021 Mar;
384(12):1089-1100.
PMID: 33761206
Background: A safe, effective vaccine is essential to eradicating human immunodeficiency virus (HIV) infection. A canarypox-protein HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/E) showed modest efficacy in reducing infection in...
13.
Baeten J, Palanee-Phillips T, Mgodi N, Mayo A, Szydlo D, Ramjee G, et al.
Lancet HIV
. 2021 Feb;
8(2):e87-e95.
PMID: 33539762
Background: Two phase 3 clinical trials showed that use of a monthly vaginal ring containing 25 mg dapivirine was well tolerated and reduced HIV-1 incidence in women by approximately 30%...
14.
Roberts S, Nair G, Baeten J, Palanee-Philips T, Schwartz K, Reddy K, et al.
AIDS Behav
. 2019 Nov;
24(5):1432-1442.
PMID: 31667678
Although vaginal microbicides for HIV prevention are designed to be female-initiated, male partner influence has been identified as one of the most significant factors impacting women's willingness and ability to...